Frontlight ResearchEarly access
Trial site
UHN-Toronto General Hospital
- 1running trial
- 8closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- Chronic kidney disease3 trials
- Deep vein thrombosis and pulmonary embolism1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- High blood pressure1 trial
- Obesity1 trial
- Pulmonary arterial hypertension1 trial
- Sickle cell disease1 trial
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Completed6 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S5 trials
- Cytokinetics1 trial
- Laval University1 trial
- Ottawa Hospital Research Institute1 trial
- Target PharmaSolutions, Inc.1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
Closed trials
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Completed
Completed
Terminated
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Terminated
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026